en

PRODUCT DETAIL

Topotecan Hospira 4 mg/4 ml infúzny koncentrát

Code 20665
MA number EU/1/10/633/001
Product Form: con inf 1x4 ml/4 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
L01CE Topoisomerase 1 inhibitors
L01CE01 Topotecan
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 10.06.2010
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 10.08.2023
eu-flag.png sk-flag.png